These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9122126)

  • 41. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
    Karlsson C; Hansson L; Celsing F; Lundin J
    Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.
    Hodgson K; Ferrer G; Pereira A; Moreno C; Montserrat E
    Br J Haematol; 2011 Jul; 154(1):14-22. PubMed ID: 21534942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literature.
    Hill J; Walsh RM; McHam S; Brody F; Kalaycio M
    Am J Hematol; 2004 Mar; 75(3):134-8. PubMed ID: 14978692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
    Moccia F; Casti P; Morra L
    Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intractable acute autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia successfully treated with vincristine-loaded platelet infusion.
    Sigler E; Shtalrid M; Goland S; Sthoeger ZM; Berrebi A
    Am J Hematol; 1995 Dec; 50(4):313-5. PubMed ID: 7485113
    [No Abstract]   [Full Text] [Related]  

  • 46. B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia.
    Maura F; Visco C; Falisi E; Reda G; Fabris S; Agnelli L; Tuana G; Lionetti M; Guercini N; Novella E; Nichele I; Montaldi A; Autore F; Gregorini A; Barcellini W; Callea V; Mauro FR; Laurenti L; Foà R; Neri A; Rodeghiero F; Cortelezzi A
    Am J Hematol; 2013 Jan; 88(1):32-6. PubMed ID: 23115077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cerebral lesions in Hodgkin's disease].
    Cambier J; Boivin P; Girauld A; Lechevalier B; Weiss AM; Lhuillier M
    Ann Med Interne (Paris); 1973 Feb; 124(2):65-74. PubMed ID: 4723743
    [No Abstract]   [Full Text] [Related]  

  • 48. [Accessory use of protease-inhibiting agents for disease remission in a patient with autoimmune hemolytic anemia associated with B-CLL].
    Ijichi S; Sano Y; Une F; Maruyama I; Osame M
    Rinsho Ketsueki; 1990 Feb; 31(2):219-23. PubMed ID: 2329684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
    Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
    Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and aetiology of anaemia in lymphoid malignancies.
    Ghosh J; Singh RK; Saxena R; Gupta R; Vivekanandan S; Sreenivas V; Raina V; Sharma A; Kumar L
    Natl Med J India; 2013; 26(2):79-81. PubMed ID: 24093980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoimmune cytopenias in chronic lymphocytic leukemia.
    Visco C; Barcellini W; Maura F; Neri A; Cortelezzi A; Rodeghiero F
    Am J Hematol; 2014 Nov; 89(11):1055-62. PubMed ID: 24912821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
    Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
    Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Levamisole in autoimmune complications of chronic lymphocytic leukemia].
    Vygovskaia Iai ; Loginskiĭ VE; Matlan VL
    Sov Med; 1989; (1):85-8. PubMed ID: 2718033
    [No Abstract]   [Full Text] [Related]  

  • 55. [Coomb's-positive hemolytic anemia and tuberculosis in Kaposi's sarcoma treated with interferon].
    Yermiahu T; Benharroch D
    Harefuah; 1994 Dec; 127(11):445-8, 503. PubMed ID: 7806102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fludarabine-induced hemolytic anemia: successful treatment by rituximab.
    Paydas S
    Hematol J; 2004; 5(1):81-3. PubMed ID: 14745435
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
    Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
    Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoimmune hemolytic anemia in chronic lymphocytic leukemia.
    Stojcevski T; Saso R; Stojanoski R; Karanfilski O
    Acta Med Iugosl; 1985; 39(4):293-9. PubMed ID: 4072768
    [No Abstract]   [Full Text] [Related]  

  • 59. Cold agglutinin disease with IgG monoclonal gammopathy in a case of chronic lymphocytic leukemia: an unusual presentation.
    Yegin ZA; Yağci M; Haznedar R
    Transfus Apher Sci; 2009 Jun; 40(3):219-20. PubMed ID: 19447678
    [No Abstract]   [Full Text] [Related]  

  • 60. Apheretic "rescue-protocol" designed for treatment of CLL associated life-threatening hemolytic crisis.
    Balint B; Todorovic-Balint M; Ljubenov M; Tarabar O; Pavlovic M; Kanjuh V
    Transfus Apher Sci; 2015 Apr; 52(2):256-8. PubMed ID: 25578651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.